Joint EFGCP & DIA: Better Medicines for Children Conference11/12/2018
The joint annual EFGCP-DIA conference took place on 25-26 October in Brussels. The aim: taking stock of the progress achieved in the paediatric field after ten years of Paediatric Regulation.
C4C conect4children Project11/12/2018
C4C conect4children project update.
The 2nd Consortium Meeting of the 'ERN-PAEDCAN PARTNER: Paediatric Rare Tumours Network – European Registry' took place on 15 September in Gdańsk, Poland.
EU Action Plan Paediatrics Medicines Development07/12/2018
2 Oct 2018: The EMA and the European Commission’s Directorate-General for Health and Food Safety (DG SANTE) published a joint action plan to support the development of medicines for children in Europe.
A new group, Young SIOPE, has been formed within SIOP Europe. The Group aims to develop a programme for young oncologists.
The Survivorship Passport06/12/2018
Stakeholders met in Brussels on 24 September 2018 to discuss the current status and challenges of the Survivorship Passport. The differences in long-term follow-up in different countries was discussed
The QUARTET Project and the SIOP Europe Paediatric Radiotherapy Working Group06/12/2018
The 2018 QUARTET group meeting: 16 October. The group gathered to discuss the status of the trials included in the QUARTET project, particularly those that will open shortly.
News Release: SIOP Europe 20th Anniversary Events09/10/2018
SIOP Europe at 20 Years
Brexit: the European Parliament’s role in prioritising patients, public health and health security a21/09/2018
With the Brexit clock ticking and with only six months left until the United Kingdom leaves the European Union, both sides are now preparing for a possible ’no deal’ Brexit, which could impact on patient and public health across the EU27.
Improving the care of children in Europe with rare cancer03/09/2018
SIOP Europe together with Coordinators for the PARTNER Project and ERN PaedCan highlight the importance of collaboration in order to improve the care of children in Europe with rare cancer.